Manufacturing, Gene Therapies

MilliporeSigma Launches Lentiviral Production Platform for Cell and Gene Therapies

October 16, 2020

The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.

Akron Bio Will Install a Cytiva FlexFactory to Manufacture Plasmid DNA

October 15, 2020

Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio.

Roche and Dyno Therapeutics to Enter into $1.8 Billion Collaboration

October 14, 2020

Roche will use Dyno’s CapsidMap platform to develop next-generation adeno-associated virus vectors for gene therapies for central nervous system diseases and liver-directed therapies.

Modernizing Bioprocessing for Gene Therapy Viral Vectors

October 03, 2020

The manufacture of gene therapy vectors is shifting to more modern technologies.

Oxgene Launches TESSA Technology for AAV Manufacture at Scale

October 01, 2020

The technology is a novel, plasmid-free manufacturing system for robust and reproducible manufacture of AAV at scale.

Fujifilm Irvine Scientific Becomes Worldwide Distributor of Cellnest

September 30, 2020

Cellnest will join Fujifilm Irvine Scientific’s PRIME-XV portfolio which consists of xeno-free and chemically defined media for stem cell culture.

Cytiva Invests $500 Million Over 5 years to Expand Global Capacity

September 14, 2020

The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.

Cobra and CombiGene Sign Agreement for Plasmid Production for Gene Therapy

September 10, 2020

The companies have signed an agreement for the production of two plasmids needed for the manufacture of CG01, a gene therapy for the treatment of drug-resistant focal epilepsy.

Catalent Invests $130 Million to Expand Gene Therapy Manufacturing Capacity

September 09, 2020

The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.

Cobra Biologics Develops Master Cell Banks for CombiGene’s Gene Therapy

August 18, 2020

The cell banks were created using current good manufacturing practices and can be used each time CombiGene produces new plasmids for the production of its gene therapy, CG01.